Insider trades › Elevance Health · Elevance Health company page
Elevance Health insider trading
Transactions in ELV stock reported by Elevance Health executives, directors and large holders on SEC Form 4 over the last 120 days. Last update 2026-10-14.
$0open-market sales (0 shares, 0 insiders)
$1.4Mopen-market purchases (3,725 shares, 2 insiders)
5Form 4 filings
Insiders
Gail Boudreaux President and CEO, Director Bought $1.0M Ramiro G Peru Director Bought $366K Mark Kaye EVP & CFO 2 other transactions Erin M Wessling EVP & Chief Legal Officer 2 other transactions Ryan R Craig EVP & Chief HR Officer 1 other transaction
All transactions
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 2, 2026 | Mark Kaye EVP & CFO | Shares withheld for tax | 4,161 | $386.43 | — | Form 4 ↗ |
| Oct 2, 2026 | Mark Kaye EVP & CFO | Grant or award | 2,627 | — | — | Form 4 ↗ |
| Sep 3, 2026 | Erin M Wessling EVP & Chief Legal Officer | Shares withheld for tax | 255 | $414.78 | — | Form 4 ↗ |
| Sep 2, 2026 | Erin M Wessling EVP & Chief Legal Officer | Shares withheld for tax | 94 | $405.84 | — | Form 4 ↗ |
| Sep 2, 2026 | Ryan R Craig EVP & Chief HR Officer | Shares withheld for tax | 144 | $405.84 | — | Form 4 ↗ |
| Jul 17, 2026 | Ramiro G Peru Director | Open-market purchase | 1,000 | $366.05 | $366K | Form 4 ↗ |
| Jul 17, 2026 | Gail Boudreaux President and CEO, Director | Open-market purchase | 680 | $366.41 | $249K | Form 4 ↗ |
| Jul 17, 2026 | Gail Boudreaux President and CEO, Director | Open-market purchase | 2,045 | $368.25 | $753K | Form 4 ↗ |
Source: SEC EDGAR, Elevance Health Form 4 filings. Values are shares × reported price for open-market trades. Insider trades are reported facts, not recommendations. Not investment advice. See the tracker for how to read the codes.